Lithium revisited: Current status, future prospects

Primary Care Psychiatry

Volumn 5, Issue 2, 1999, Pages 41-48

  McIntyre, Roger S ^a   Parikh, Sagar V ^a   Kennedy, Sidney H ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Augmentation; Efficacy; Lithium; Renal toxicity; Suicide; Teratogenicity; Withdrawal

Indexed keywords

LITHIUM;

CLINICAL OBSERVATION; DRUG DEVELOPMENT; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MORTALITY; NEPHROTOXICITY; PRIORITY JOURNAL; REVIEW; TERATOGENICITY;

EID: 0032866169     PISSN: 13552570     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Moncrieff J. Lithium: evidence reconsidered. Br J Psychiat 1997; 171:113-119.
2. Kaplan HI, Sadock BJ. In Comprehensive Textbook of Psychiatry, 6th edn, Vol I/II. Williams & Wilkins, 1995.
3. Cade JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36:349-352.
4. Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A. Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970; 326-330.
5. Baastrup PC, Shou M. Lithium as a prophylactic agent: its effect against recurrent depression and manic-depressive psychosis. Arch Gen Psychiat 1967; 16:162-172.
6. Kusumakar V, Yatham LN, Haslam DRS, Parikh SV, Matte R, Silverstone PH et al. Treatment of mania, mixed states and rapid cycling. Can J Psychiat 1976; 42:79S-86S.
7. Gabbard GO. In Treatments of Psychiatric Disorders, 2nd edn, Vol I. APA Press, 1995.
8. Campbell M, Kafantaris V, Cueva J. An update on the use of lithium carbonate in aggressive children and adolescents with conduct disorder. Psychopharmacol Bull 1995; 31:93-102.
9. McDougle CJ. Update on pharmacological management of OCD: agents and augmentation. J Clin Psychiat 1997; 58:11S-17S.
10. Goodnick PJ, Meltzer HY. Treatment of schizoaffective disorders. Schizophrenia Bull 1984; 10:30-48.
11. Lejoyeux M, Ades J. Evaluation of lithium treatment in alcoholism. Alcohol Alcoholism 1993; 287:273-279.
12. Shou M. Lithium in the treatment of other psychiatric and nonpsychiatric disorders. Arch Gen Psychiat 1979; 36:856-959.
13. Post RM, Frye MA, Leverich GS, Denicoff KD. The role of complex combination therapy in the treatment of refractory bipolar illness. CNS Spectrum 1998; 3:66-86.
14. Greil W, Kleindienst N, Erazo N. Müller-Oerlinghausen B. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 1998; 18:455-460.
15. Pope HG, McElroy SL, Keck PE, Hudson JI. Valproate in the treatment of acute mania. Arch Gen Psychiat 1991; 48:62-68.
16. Keck PE, McElroy SL. Tugrul KC, Bennett JA. Valproate oral loading in the treatment of acute mania. J Clin Psychiat 1993; 54:305-308.
17. Hestbech J, Hansen H, Amdisen A. Olsen S. Chronic renal lesions following long-term treatment with lithium. Kidney Int 1997; 12:205-213.
18. Baldessarini RJ. Tondo L. Faedda GL. Suppes TR, Floris G, Rudas N. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J Clin Psychiat 1996; 57:441-448.
19. Blackwell B, Shepherd M. Prophylactic lithium: another therapeutic myth? Lancet 1968; 968-971.
20. Moncrieff J. Lithium revisited: a re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder. Br J Psychiat 1995; 167:569-574.
21. Goodwin FK, Jamison KR. In Manic-depressive Illness: Oxford University Press, 1990.
22. Bowden CL. Brugger AM, Swann AC. Calabrese JR, Janicak PG, Petty F et al. Efficacy of divalproex vs lithium and placebo in treatment of mania. J Am Med Assoc 1994; 271:918-924.
23. Garfinkel PE, Stancer HC, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Dis 1980; 2:279-288.
24. McElroy SL, Keck PE, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM et al. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiat 1996; 57:142-146.
25. Prien RF, Caffey EM, Klett CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania: report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiat 1972; 26:146-153.
26. Mukherjee S, Rosen AM, Caracci G, Shukla S. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiat 1986; 43:342-346.
27. Noack CH, Trautner EM. The lithium treatment of maniacal psychosis. Med J Aust 1951; 219-222.
28. Harrow M, Goldberg JF, Grossman LS, Meltzer HY. Outcome in manic disorders. Arch Gen Psychiat 1990; 47:665-671.
29. Keller MB, Lavori PW, Coryell W, Endicott J, Mueller TI. Bipolar I: a five-year prospective follow-up. J Nervous Mental Dis 1993; 181:238-245.
30. Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP. Lithium prophylaxis of bipolar illness. Br J Psychiat 1994; 164:208-214.
31. Post RM, Frye MA, Denicoff KD, Leverich GS, Kimbrell TA, Dunn RT. Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology 1996; 19:206-219.
32. Guscott R, Taylor L. Lithium prophylaxis in recurrent affective illness. Br J Psychiat 1994; 164:741-746.
33. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. New Engl J Med 1989; 321:1498-1493.
34. De Montigny C, Grunberg F, Mayer A, Des Chenes JP. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiat 1981; 138:252-256.
35. Rouillon F, Gorwood P. The use of lithium to augment antidepressant medication. J Clin Psychiat 1998; 59:32S-39S.
36. Thase ME, Kupfer DJ, Frank E, Jerret DB. Treatment of imipramine-resistant recurrent depression: II. An open clinical trial of lithium augmentation. J Clin Psychiat 1989; 50:413-417.
37. Johnson G. Lithium-early development, toxicity, and renal function. Neuropsychopharmacology 1998; 19:200-205.
38. Bendz H, Aurell M, Balldin J, Mathe AA, Sjodin I. Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dialysis Transplant 1994; 9:250-1254.
39. Walker R. Lithium nephrotoxicity. Kidney Int 1993; 42:93S-98S.
40. Bucht G, Wahlin A. Renal concentrating capacity in long term lithium treatment and after withdrawal of lithium. Acta Med Scand 1980; 207:309-314.
41. Cohen LS, Fredman JM, Jefferson JN, Johnson EM, Weiner ML. A reevaluation of risk of in utero exposure to lithium. J Am Med Assoc 1994; 271:146-150.
42. Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiat 1991; 48:1082-1088.
43. Dunner DL. Murphy D, Stallone F, Fieve RR. Episode frequency prior to lithium treatment in bipolar manic-depressive patients. Comp Psychiat 1979; 20:511-515.
44. Baldessarini RJ, Tondo L, Faedda GL. Suppes TR, Floris G, Rudas N. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J Clin Psychiat 1996; 57:441-448.
45. Plenge P, Mellerup ET, Norgaard T. Functional and structural rat kidney changes caused by peroral or parental lithium treatment. Acta Psychiat Scand 1981; 63:303-313.
46. Wallin L, Alling C. Effect of sustained-release lithium tablets on renal function. Br Med J 1979; 2:1332.
47. Hetmar O, Brun C. Clemmesen L, Ladegofed J, Larsen S. Rafaelson O. Lithium: long-term effects on the kidney. II Structural changes. J Psychiat Res 1987; 21:279-288.
48. Perry PJ, Dunner FJ, Hahn RL, Tsuang MT, Berg MJ. Lithium kinetics in single daily dosing. Acta Psychiat Scand 1981; 64:281-294.
49. Abraham G, Waldron JJ, Lawson JS. Are the renal effects of lithium modified by frequency of administration. Acta Psychiat Scand 1995; 92:115-118.
50. Black DW, Winokur G, Nasrallah A. Is death from natural causes still excessive in psychiatric patients? J Nervous Mental Dis 1987; 175:674-680.
51. Weeke A. Causes of death in manic-depressives. In Origin, Prevention and Treatment of Affective Disorders. Shou M, Stromgren E (editors). London: Academic Press, 1979; pp. 289-299.
52. Musselman DL, Evans DL. Nemeroff CB. The relationship of depression to cardiovascular disease. Arch Gen Psychiat 1998; 55:580-592.
53. Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Aida M Schou M et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive illness and schizoaffective illness. Acta Psychiat Scand 1992; 86:218-222.
54. Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmacopsychiatry 1996; 29:103-107.
55. Coppen A, Standish-Baryy H, Bailey J, Houston G, Silocks P, Hermon C. Does lithium reduce the mortality of recurrent mood disorders? J Affect Dis 1991; 23:1-7.
56. Ahrens B, Müller-Oerlinghausen B, Schou M, Wolf T, Aldas M, Grof E et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Dis 1995; 33:67-75.
57. Sheard MH, Marini JL, Bridges CI, Wagner E. The effects of lithium on impulsive aggressive behaviour in man. Am J Psychiat 1976; 33:1409-1413.